Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Penn Pharma To Expand High Containment Ops | Contract Pharma

What are you searching for?

Sign in
Breaking News

Penn Pharma To Expand High Containment Ops

To make $22 million investment in services expansion

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Penn Pharma will invest $22 million in its South Wales, UK facility to expand its high containment facilities with a 15,000-sq.-ft. new development and commercial manufacturing unit for tablets and
capsules.

Penn Pharma’s chief executive officer, Dr. Richard Yarwood, said, “We are delighted to announce this significant investment in the UK pharmaceutical manufacturing sector at a time when the established industry remodels itself and outsourcing is on the increase. This investment is the catalyst required to enable us to build on the services that we are currently offering our clients and ensure that we are able to react to the evolving market place. We have seen a growth in the number of highly potent compounds coming through the pharmaceutical early phase pipeline and in response to this we are investing in an expansion of our existing resources to meet this growing demand.”

The company received additional funding and training support from the Welsh Assembly Government.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics